Hypoxia and drug resistance

Cited by (564)

Items 101–200 of 564

1. AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells
   Tsutomu Shimura, Naoto Noma, Yui Sano, Yasushi Ochiai, Toshiyuki Oikawa, Manabu Fukumoto, Naoki Kunugita · 2014 · Radiotherapy and Oncology
2. Mutagenesis induced by the tumor microenvironment
   Jianling Yuan, Peter M. Glazer · 1998 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
3. Mathematical modeling of cancer progression and response to chemotherapy
   Sandeep Sanga, John P. Sinek, Hermann B. Frieboes, Mauro Ferrari B, John P. Fruehauf, Vittorio Cristini C · 2006 · Expert Review of Anticancer Therapy
4. Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells
   Zhenyu Ding, Yang Li, Xiaodong Xie, Fangwei Xie, Feng Pan, Jianjun Li, Jianming He, Houjie Liang · 2010 · Journal of Cancer Research and Clinical Oncology
5. Apoptotic body–mediated intercellular delivery for enhanced drug penetration and whole tumor destruction
   Dongyang Zhao, Wenhui Tao, Songhao Li, Yao Chen, Yinghua H. Sun, Zhonggui He, Bingjun Sun, Jin Sun · 2021 · Science Advances
6. SIRT1 and AMPK Mediate Hypoxia-Induced Resistance of Non–Small Cell Lung Cancers to Cisplatin and Doxorubicin
   Dong Hoon Shin, Yong‐Joon Choi, Jong‐Wan Park · 2013 · Cancer Research
7. Hypoxia-induced cell death in human malignant glioma cells: energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death
   Jörg Steinbach, Hartwig Wolburg, Andrea Klumpp, H Probst, Michael Weller · 2003 · Cell Death and Differentiation
8. Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1
   Chii-Wen Chou, Chi-Chung Wang, Chung‐Pu Wu, Yu‐Jung Lin, Yu-Chun Lee, Ya-Wen Cheng, Chia‐Hung Hsieh · 2012 · Neuro-Oncology
9. Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues
   H. J. Kim, Ho Zoon Chae, YUN‐JEONG KIM, Yeul Hong Kim, Tae Sook Hwang, E.-M. Park, Y.-M. Park · 2003 · Cell Biology and Toxicology
10. Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors.
    Oliver Thews, D K Kelleher, Peter W. Vaupel · 2001 · PubMed
11. Tumor-induced modulation of dendritic cell function
    Eva Gottfried, Marina P Kreutz, Andréas Mackensen · 2007 · Cytokine & Growth Factor Reviews
12. Hypoxia-mediated autophagic flux inhibits silver nanoparticle-triggered apoptosis in human lung cancer cells
    Jae‐Kyo Jeong, Sangiliyandi Gurunathan, Min-Hee Kang, Jae Woong Han, Joydeep Das, Yun‐Jung Choi, Deug‐Nam Kwon, Ssang‐Goo Cho, Chankyu Park, Han Geuk Seo et al. · 2016 · Scientific Reports
13. Hypoxia Induced Resistance to Doxorubicin in Prostate Cancer Cells is Inhibited by Low Concentrations of Glyceryl Trinitrate
    Lisa J. Frederiksen, David Robert Siemens, Jeremy P.W. Heaton, Lori Maxwell, MICHAEL A. ADAMS, Charles H. Graham · 2003 · The Journal of Urology
14. Plasma angiopoietin‐1, angiopoietin‐2 and Tie‐2 in breast and prostate cancer: a comparison with VEGF and Flt‐1
    G. J. Caine, Andrew D. Blann, Paul S. Stonelake, Peter Ryan, Gregory Y.H. Lip · 2003 · European Journal of Clinical Investigation
15. Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
    M Volm, Thomas Efferth · 2015 · Frontiers in Oncology
16. Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α
    Yue Pan, Dan Shao, Yawei Zhao, Fan Zhang, Xiao Zheng, Yongfei Tan, Kan He, Jing Li, Li Chen · 2017 · International Journal of Biological Sciences
17. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines
    BertrandC. Liang · 1996 · Journal of Neuro-Oncology
18. Pim-1 plays a pivotal role in hypoxia-induced chemoresistance
    Jianfeng Chen, Masanobu Kobayashi, Stephanie Darmanin, Y. Qiao, Christopher P Gully, Ran Zhao, Sai‐Ching J. Yeung, Mong‐Hong Lee · 2009 · Oncogene
19. Optical Imaging of Tumor Hypoxia and Evaluation of Efficacy of a Hypoxia-Targeting Drug in Living Animals
    Hiroshi Harada, Shinae Kizaka‐Kondoh, Masahiro Hiraoka · 2005 · Molecular Imaging
20. Immune cells as tumor drug delivery vehicles
    Francis Combes, Evelyne Meyer, Niek N. Sanders · 2020 · Journal of Controlled Release
21. Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: Potential to guide treatment? A systematic review
    Jonathan M. Bernstein, Jarrod James Homer, Catharine West · 2014 · Oral Oncology
22. Hypoxia-Induced Resistance to Chemotherapy in Cancer
    Lori M. Minassian, Tiziana Cotechini, Erin Huitema, Charles H. Graham · 2019 · Advances in experimental medicine and biology
23. Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2
    Hideaki Nakamura, Keiji Tanimoto, Keiko Hiyama, Mayu Yunokawa, Takeshi Kawamoto, Yukio Kato, Koji YOSHIGA, Lorenz Poellinger, Eiso Hiyama, Masahiko Nishiyama · 2008 · Oncogene
24. Oxygen-mediated Regulation of Tumor Cell Invasiveness
    Lynne-Marie M Postovit, MICHAEL A. ADAMS, Gendie E. Lash, Jeremy P.W. Heaton, Charles H. Graham · 2002 · Journal of Biological Chemistry
25. Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair.
    A Kondo, R Safaei, M Mishima, H Niedner, Xinjian Lin, Stephen B. Howell · 2001 · PubMed
26. Microtissue size and hypoxia in HTS with 3D cultures
    Amish Asthana, William S. Kisaalita · 2012 · Drug Discovery Today
27. Cytotoxicity of Paclitaxel Incorporated in PLGA Nanoparticles on Hypoxic Human Tumor Cells
    Cheng S. Jin, Ling Bai, Hong Wu, Wenjie Song, Guozhen Guo, Kefeng Dou · 2009 · Pharmaceutical Research
28. Hypoxia Up-Regulates Telomerase Activity via Mitogen-Activated Protein Kinase Signaling in Human Solid Tumor Cells
    Hiroyuki Seimiya, Masanori Tanji, Tomoko Oh‐hara, Akihiro Tomida, Imad Naasani, Takashi Tsuruo · 1999 · Biochemical and Biophysical Research Communications
29. BNIP3 as a Progression Marker in Primary Human Breast Cancer; Opposing Functions inIn situVersus Invasive Cancer
    Ern Yu Tan, Leticia Campo, Cheng Han, Helen Turley, Francesco Pezzella, Kevin C. Gatter, Adrian Llewellyn Harris, Stephen B. Fox · 2007 · Clinical Cancer Research
30. Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells
    Dongdong Chen, Mingke Song, Osama Mohamad, Shan Ping Yu · 2014 · BMC Cancer
31. Gene expression and hypoxia in breast cancer
    Elena Favaro, Simon Lord, Adrian Llewellyn Harris, Francesca Meteora Buffa · 2011 · Genome Medicine
32. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
    Nobuko Koshikawa, Keizo Takenaga, M Tagawa, Shigeru Sakiyama · 2000 · PubMed
33. Transfer hydrogenation catalysis in cells
    Samya Banerjee, Peter John Sadler · 2020 · RSC Chemical Biology
34. Killing Hypoxic Cell Populations in a 3D Tumor Model with EtNBS-PDT
    Conor L. Evans, Adnan O. Abu‐Yousif, Yong Jin Park, Oliver J. Klein, Jonathan P. Celli, Imran Rizvi, Xiang Zheng, Tayyaba G. Hasan · 2011 · PLoS ONE
35. Diffuse Optical Spectroscopy Evaluation of Treatment Response in Women with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
    Omar Falou, Hany Soliman, Ali Sadeghi Naini, Sara Iradji, Sharon Lemon-Wong, Judit T. Zubovits, Jacqueline Spayne, Rebecca Alexandra Dent, Maureen Trudeau, Jean Francois Boileau et al. · 2012 · Translational Oncology
36. Hypoxia in head and neck cancer
    Aidah Isa, Tim H. Ward, Catharine West, Nicholas J Slevin, Jarrod James Homer · 2006 · British Journal of Radiology
37. Is the hypoxia-inducible factor pathway important in gastric cancer?
    Ewen Alexander Griffiths, Susan Anne Pritchard, I. Welch, Pat Price, Catharine West · 2005 · European Journal of Cancer
38. Cellular response to tissue hypoxia and its involvement in disease progression
    Eiji Ikeda · 2005 · Pathology International
39. A protective role for HIF-1 in response to redox manipulation and glucose deprivation: Implications for tumorigenesis
    Williams, Kaye J, Telfer, Brian A, Airley, Rachel E, Peters, Hans PW, Sheridan, Mary R, van der Kogel, Albert J, Harris, Adrian L, Stratford, Ian J · 2002 · Oncogene
40. iNOS as a therapeutic target for treatment of human tumors
    Brian Fitzpatrick, Manal Mehibel, Rachel L. Cowen, Ian James Stratford · 2008 · Nitric Oxide
41. Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis
    Zhang, D, Shi, Z, Li, M, Mi, J · 2014 · Cell Death & Disease
42. Azo-based small molecular hypoxia responsive theranostic for tumor-specific imaging and therapy
    Ying Mei Zhou, Mrinmoy Maiti, Amit Kumar Sharma, Miae Won, Le Yu, Lan Xi Miao, Jin Woo Shin, Arup Podder, Kondapa Naidu Bobba, Jiyou Han et al. · 2018 · Journal of Controlled Release
43. Prognostic Value of Pretreatment 18F-FDG PET/CT Parameters Including Visual Evaluation in Patients With Head and Neck Squamous Cell Carcinoma
    Sho Koyasu, Yuji Nakamoto, Masahiro Kikuchi, Kayo Suzuki, Kohei Hayashida, Kyo Itoh, Kaori Togashi · 2014 · American Journal of Roentgenology
44. Erythropoietin for patients with malignant disease
    Julia Bohlius, Simon Langensiepen, Guido Schwarzer, Jerome Seidenfeld, Margaret Piper, C Bennet, Andreas Engert · 2004 · Cochrane Database of Systematic Reviews
45. Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors
    Anette Raa, C. T. Stansberg, Vidar Martin Steen, Rolf Bjerkvig, Rolf Kåre Reed, Linda E. B. Stuhr · 2007 · BMC Cancer
46. The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying Treatments
    Ilse J. Hoogsteen, Henri A. M. Marres, A.J. van der Kogel, Johannes H.A.M. Kaanders · 2007 · Clinical Oncology
47. Evolving concepts in the management of drug resistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance
    David James Pinato, Janet Graham, Hani Gabra, Rohini Sharma · 2012 · Cancer Treatment Reviews
48. Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome
    Jae‐Young Kim, Joo‐Yong Lee · 2017 · International Journal of Molecular Sciences
49. Targeting tumour hypoxia in breast cancer
    Manuela Milani, Adrian Llewellyn Harris · 2008 · European Journal of Cancer
50. Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells
    Géza Ács, Mei Chen, Xiaowei Xu, Peter Istvan Acs, Ajay Mark Verma, Cameron J. Koch · 2004 · Cancer Letters
51. Long-term monitoring in a microfluidic system to study tumour spheroid response to chronic and cycling hypoxia
    Samantha M. Grist, S. Soroush Nasseri, Loïc Laplatine, Jonathan C. Schmok, Dickson R. Yao, Jessica Hua, Lukas Chrostowski, Karen C. Cheung · 2019 · Scientific Reports
52. Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study
    Natasha S. Shah, Jessica Gibbs, Dulcy Wolverton, Albert E. Cerussi, Nola Hylton, Bruce J. Tromberg · 2005 · Journal of Biomedical Optics
53. Effect of hypoxia-inducible factor-1α on transcription of survivin in non-small cell lung cancer
    Yuqing Chen, Chengling Zhao, Wěi Li · 2009 · Journal of Experimental & Clinical Cancer Research
54. Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids
    Hari R. Kumar, Xiaoling Zhong, Derek J. Hoelz, Frederick J. Rescorla, Robert J. Hickey, Linda H. Malkas, John A. Sandoval · 2008 · Pediatric Surgery International
55. Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions
    Xin Zhang, Kaikai Ding, Jian Wang, Xingang Li, Peng Zhao · 2018 · Biomedicine & Pharmacotherapy
56. A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy
    Gerard C. van Rhoon, Martine Franckena, Timo L.M. ten Hagen · 2020 · Advanced Drug Delivery Reviews
57. Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme
    Wei-Ling Chen, Chi-Chung Wang, Yu‐Jung Lin, Chung‐Pu Wu, Chia‐Hung Hsieh · 2015 · Journal of Translational Medicine
58. Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1
    Kym Sutton, Shaista Hayat, N-M Chau, Simon J. Cook, Jacques Pouysségur, Afshan Ahmed, Nina P. Perusinghe, Renaud LeFloch, Jun Yang, Margaret A. Ashcroft · 2007 · Oncogene
59. 1,2,5-Oxadiazole N-oxide derivatives as potential anti-cancer agents: synthesis and biological evaluation. Part IV
    Mariana Boiani · 2001 · European Journal of Medicinal Chemistry
60. Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α
    Sreenivasulu Chintala, Károly Tóth, Shousong Cao, Farukh A. Durrani, Mary M. Vaughan, Randy L. Jensen, Youcef M. Rustum · 2010 · Cancer Chemotherapy and Pharmacology
61. Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism
    Xuan Yi, Hoon Hur, In‐Hye Ham, Jisoo Yun, Ji-Yoon Lee, Wooyoung Shim, Young Bae Kim, Gwang Lee, Sang‐Uk Han, Yong Kwan Cho · 2013 · Experimental Cell Research
62. Pigment Epithelium–Derived Factor Gene Therapy Inhibits Human Pancreatic Cancer in Mice
    Ryunosuke Hase, Masaki Miyamoto, Hirofumi Uehara, Masatoshi Kadoya, Yuma Ebihara, Yoshihiro Murakami, Ryo Takahashi, Seiji Mega, Li Li, Toshiaki Shichinohe et al. · 2005 · Clinical Cancer Research
63. Correlation between Hepatic Tumor Blood Flow and Glucose Utilization in a Rabbit Liver Tumor Model
    Errol E. Stewart, Xaiogang Chen, Jennifer A. Hadway, Ting‐Yim Lee · 2006 · Radiology
64. Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer
    Qu Zhang, Chi Zhang, Xi Yang, Baixia Yang, Jinfeng Wang, Yahui Kang, Zhongming Wang, Defan Li, Guanhong Huang, Zhaoming Ma et al. · 2014 · Diagnostic Pathology
65. Enamine N -Oxides: Synthesis and Application to Hypoxia-Responsive Prodrugs and Imaging Agents
    Dahye Kang, Sheldon T. Cheung, Andrew Wong-Rolle, Justin Kim · 2021 · ACS Central Science
66. Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G1 phase cell cycle arrest
    Sayaka Yoshiba, Daisuke Ito, Tatsuhito Nagumo, Tatsuo Shirota, Masashi Hatori, Satoru Shintani · 2008 · Oral Oncology
67. Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors
    Stephanie Lemmo Ham, Ramila Joshi, Gary D. Luker, Hossein Tavana · 2016 · Advanced Healthcare Materials
68. Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations
    Nanda C. Krak, Adriaan A. Lammertsma, Otto S. Hoekstra · 2004 · European Journal of Nuclear Medicine and Molecular Imaging
69. HER-2 Gene Amplification Correlates with Higher Levels of Angiogenesis and Lower Levels of Hypoxia in Primary Breast Tumors
    Kimberly Blackwell, Mark W. Dewhirst, Vlayka B. Liotcheva, Stacey A. Snyder, Gloria Broadwater, Rex C. Bentley, Anita Lal, Gregory Joseph Riggins, Steve Anderson, Jim Vredenburgh et al. · 2004 · Clinical Cancer Research
70. The impact of anaemia on outcome in cancer
    Helen Clarke, Christopher J Pallister · 2005 · Clinical & Laboratory Haematology
71. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells
    Hui‐Hsuan Lin, Chia-Wen Tsai, Fen‐Pi Chou, Chau‐Jong Wang, Shu‐Wen Hsuan, Cheng-Kun Wang, Jing‐Hsien Chen · 2010 · Toxicology and Applied Pharmacology
72. Tumour Hypoxia: Impact on Biology, Prognosis and Treatment of Solid Malignant Tumours
    M. Weinmann, Claus Belka, Ludwig Plaßwilm · 2004 · Oncology Research and Treatment
73. Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles
    Joshua Owen, Conor McEwan, Heather Nesbitt, Phurit Bovornchutichai, Raymond Averre, Mark Andrew Borden, A. P. McHale, John F. Callan, Eleanor Stride · 2016 · PLoS ONE
74. Hypoxia‐Induced Acidification Causes Mitoxantrone Resistance Not Mediated by Drug Transporters in Human Breast Cancer Cells
    A.E. Greijer, Mariska C. de Jong, George L. Scheffer, A. Shvarts, P. J. van Diest, Elsken van der Wall · 2005 · Analytical Cellular Pathology
75. Functional Integrity of Nuclear Factor κB, Phosphatidylinositol 3′-Kinase, and Mitogen-Activated Protein Kinase Signaling Allows Tumor Necrosis Factor α-Evoked Bcl-2 Expression to Provoke Internal Ribosome Entry Site-Dependent Translation of Hypoxia-Inducible Factor 1α
    Jie Zhou, Melvin Callapina, Gregory J. Goodall, Bernhard Brüne · 2004 · Cancer Research
76. Hypoxia Inhibits Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Blocking Bax Translocation
    Moonil Kim, Sang-Youel Park, Hyun‐Sook Pai, Tae‐Hyoung Kim, Timothy R. Billiar, Dai‐Wu Seol · 2004 · Cancer Research
77. Tumor-Endothelial Interaction Links the CD44+/CD24- Phenotype with Poor Prognosis in Early-Stage Breast Cancer
    Martin Buess, Michal Rajski, Brigitte Vogel, Richard Herrmann, Christoph F. Rochlitz · 2009 · Neoplasia
78. The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors
    Jiuda Zhao, Feng Du, Yang Luo, Guoshuang Shen, Fangchao Zheng, Binghe Xu · 2015 · Cancer Treatment Reviews
79. Nitric oxide‐mediated regulation of hypoxia‐induced B16F10 melanoma metastasis
    Lynne-Marie M Postovit, MICHAEL A. ADAMS, Gendie E. Lash, Jeremy P.W. Heaton, Charles H. Graham · 2003 · International Journal of Cancer
80. Hypoxia Induces Autophagy through Translational Up-Regulation of Lysosomal Proteins in Human Colon Cancer Cells
    Ming‐Chih Lai, Chiao-May Chang, H. Sunny Sun · 2016 · PLoS ONE
81. Hypoxia-responsive miR-210 promotes self-renewal capacity of colon tumor-initiating cells by repressing ISCU and by inducing lactate production
    Pit Ullmann, Komal Qureshi-Baig, Fabien Rodriguez, Aurélien Ginolhac, Yannic Nonnenmacher, Dominik Ternes, Jil Weiler, Karoline Gäbler, Christelle Bahlawane, Karsten Hiller et al. · 2016 · Oncotarget
82. Importance of hypoxia in the biology and treatment of brain tumors
    Jonathan P.S. Knisely, Sara Rockwell · 2002 · Neuroimaging Clinics of North America
83. A Novel Design Strategy for Stable Metal Complexes of Nitrogen Mustards as Bioreductive Prodrugs
    Laurie L. Parker, Stephen M. Lacy, Louis J. Farrugia, Cameron Evans, David J. Robins, C. Caroline O’Hare, John Anthony Hartley, Mohammed Jaffar, Ian James Stratford · 2004 · Journal of Medicinal Chemistry
84. ERK/MAPK activation involves hypoxia‐induced MGr1‐Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer
    Lili Liu, Hongbo Zhang, Li Jun Sun, Yuqi Gao, Haifeng Jin, Shuhui Liang, Yanxia Wang, Mingqing Dong, Yongquan Shi, Zhichao Li et al. · 2009 · International Journal of Cancer
85. Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours
    Adam Vorn Patterson, Kaye Janine Williams, Rachel L. Cowen, Mohammed Jaffar, Brian A. Telfer, Mark P. Saunders, Rachel E. Airley, Davina Jean Honess, A.J. van der Kogel, C. Roland Wolf et al. · 2002 · Gene Therapy
86. Effect of Antisense Hypoxia-inducible Factor 1?? on Progression, Metastasis, and Chemosensitivity of Pancreatic Cancer
    Chang, Qing, Qin, Renyi, Huang, Tao, Gao, Jun, Feng, Yanping · 2006 · Pancreas
87. Spatial Reorganization of Saccharomyces cerevisiae Enolase To Alter Carbon Metabolism under Hypoxia
    Natsuko Miura, Masahiro Shinohara, Yohei Tatsukami, Yasuhiko Sato, Hironobu Morisaka, Kouichi Kuroda, Mitsuyoshi Ueda · 2013 · Eukaryotic Cell
88. Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy
    Mingxing Yin, Songwei Tan, Yuling Bao, Zhiping Zhang · 2017 · Journal of Controlled Release
89. Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1α signaling pathway
    Yuan Qin, Huijuan Liu, Meng Li, Denghui Zhai, Yuanhao Tang, Lan Yang, Kailiang Qiao, Jiahuan Yang, Weilong Zhong, Qiang Zhang et al. · 2018 · EBioMedicine
90. Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays
    Rachel E. Airley, Andrew Robert Evans, Ali Mobasheri, Stephen M. Hewitt · 2010 · Annals of Anatomy - Anatomischer Anzeiger
91. Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells
    Linda Holmquist Mengelbier, Annika Jögi, Sven Påhlman · 2005 · International Journal of Cancer
92. Current and future uses of positron emission tomography in breast cancer imaging
    William B. Eubank, David A. Mankoff · 2004 · Seminars in Nuclear Medicine
93. Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein
    Roberta Fruttero, Marco Crosetti, Konstantin Yu. Chegaev, Stefano Guglielmo, Alberto Gasco, Francesco Berardi, Mauro Niso, Roberto Perrone, Maria Antonietta Panaro, Nicola Antonio Colabufo · 2010 · Journal of Medicinal Chemistry
94. Hypoxia and oxidative stress in breast cancer Tumour hypoxia – therapeutic considerations
    Kaye Janine Williams, Rachel L. Cowen, Ian James Stratford · 2001 · Breast Cancer Research
95. Role of protein kinase Cδ in transmitting hypoxia signal to HSF and HIF‐1
    Sun‐Hee Baek, U Youn Lee, Eun‐Mi Park, Mi‐Young Han, Yun‐Sil Lee, Young‐Mee Park · 2001 · Journal of Cellular Physiology
96. Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: Potentiation by irradiation
    Hong Gong, Christoph Pöttgen, Georg Stüben, W. Havers, Martin Stuschke, Lothar Schweigerer · 2003 · International Journal of Cancer
97. Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells
    Jiangchuan Sun, Mingyue Yin, Shenyin Zhu, Li Liu, Yi Zhu, Zhigang Wang, Ronald X. Xu, Shufang Chang · 2015 · Ultrasonics Sonochemistry
98. A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer
    Matthew T. McKenna, Jared A. Weis, Stephanie L. Barnes, Darren R. Tyson, Michael I. Miga, Vito Quaranta, Thomas E. Yankeelov · 2017 · Scientific Reports
99. Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms
    Shyambabu Chaurasiya, Nanhai G. Chen, Susanne Gray Warner · 2018 · Cancers
100. Molecular and pharmacological strategies to overcome multidrug resistance
     Jennifer A. Shabbits, Rajesh Krishna, Lawrence D. Mayer · 2001 · Expert Review of Anticancer Therapy